Search research articles
Contact Us
Filters
Showing results (261-270 of 528) with videos related to
Page
of 53
Sort By:
Human Mutation
|
October 13, 2011
ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes
Amanda B Spurdle, Sue Healey, Andrew Devereau, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
August 4, 2020
Tumor detection rates in screening of individuals with SDHx-related hereditary paraganglioma-pheochromocytoma syndrome
Samantha E Greenberg, Michelle F Jacobs, Heather Wachtel, et al.
Cancer Genetics
|
April 27, 2024
Clinical management of TP53 mosaic variants found on germline genetic testing
Abigail Ward, Dana Farengo-Clark, Danielle B McKenna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 2009
Phase II Trial of Temozolomide and Sorafenib in Advanced Melanoma Patients with or without Brain Metastases
Ravi K Amaravadi, Lynn M Schuchter, David F McDermott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2007
Estrogen receptor status could modulate the genomic pattern in familial and sporadic breast cancer
Lorenzo Melchor, Emiliano Honrado, Jia Huang, et al.
Molecular and Cellular Biology
|
September 11, 2013
The FBXO4 tumor suppressor functions as a barrier to BRAFV600E-dependent metastatic melanoma
Eric K Lee, Zhaorui Lian, Kurt D'Andrea, et al.
Stem Cell Reports
|
April 16, 2017
High-Throughput and Cost-Effective Characterization of Induced Pluripotent Stem Cells
Matteo D'Antonio, Grace Woodruff, Jason L Nathanson, et al.
Nature Communications
|
January 22, 2015
Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas
Lauren Fishbein, Sanika Khare, Bradley Wubbenhorst, et al.
Journal of Cutaneous Pathology
|
December 16, 2018
NRAS Q61R and BRAF G466A mutations in atypical melanocytic lesions newly arising in advanced melanoma patients treated with vemurafenib
Vishwas Parekh, Joseph Sobanko, Christopher J Miller, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 24, 2020
Association of premenopausal risk-reducing salpingo-oophorectomy with breast cancer risk in BRCA1/2 mutation carriers: Maximising bias-reduction
Neda Stjepanovic, Guillermo Villacampa, Kevin T Nead, et al.
Page
of 53
Search research articles
Search
Showing results (261-270 of 528) with videos related to
Sort By:
Page
of 53
Human Mutation
|
October 13, 2011
ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes
Amanda B Spurdle, Sue Healey, Andrew Devereau, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
August 4, 2020
Tumor detection rates in screening of individuals with SDHx-related hereditary paraganglioma-pheochromocytoma syndrome
Samantha E Greenberg, Michelle F Jacobs, Heather Wachtel, et al.
Cancer Genetics
|
April 27, 2024
Clinical management of TP53 mosaic variants found on germline genetic testing
Abigail Ward, Dana Farengo-Clark, Danielle B McKenna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 2009
Phase II Trial of Temozolomide and Sorafenib in Advanced Melanoma Patients with or without Brain Metastases
Ravi K Amaravadi, Lynn M Schuchter, David F McDermott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2007
Estrogen receptor status could modulate the genomic pattern in familial and sporadic breast cancer
Lorenzo Melchor, Emiliano Honrado, Jia Huang, et al.
Molecular and Cellular Biology
|
September 11, 2013
The FBXO4 tumor suppressor functions as a barrier to BRAFV600E-dependent metastatic melanoma
Eric K Lee, Zhaorui Lian, Kurt D'Andrea, et al.
Stem Cell Reports
|
April 16, 2017
High-Throughput and Cost-Effective Characterization of Induced Pluripotent Stem Cells
Matteo D'Antonio, Grace Woodruff, Jason L Nathanson, et al.
Nature Communications
|
January 22, 2015
Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas
Lauren Fishbein, Sanika Khare, Bradley Wubbenhorst, et al.
Journal of Cutaneous Pathology
|
December 16, 2018
NRAS Q61R and BRAF G466A mutations in atypical melanocytic lesions newly arising in advanced melanoma patients treated with vemurafenib
Vishwas Parekh, Joseph Sobanko, Christopher J Miller, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 24, 2020
Association of premenopausal risk-reducing salpingo-oophorectomy with breast cancer risk in BRCA1/2 mutation carriers: Maximising bias-reduction
Neda Stjepanovic, Guillermo Villacampa, Kevin T Nead, et al.
Page
of 53